NEWS NEWS IN BRIEF
HAVE YOU MADE AN IMPACT?
GSK and The King’s Fund has launched the 2016 GSK IMPACT Awards, which recognise the achievements of health and well- being chartities across the UK.
The Awards, which are in their nineteenth year, are open to charities with an annual income of between £25,000 and £2 million that are at least three years old. The name ‘IMPACT’ derives from the criteria that winners must have demonstrated in their application submissions: Innovation, Management, Partnership, Achievement, Community Focus and Targeting Need.
In 2015, £340,000 in prize money was awarded to charities through the GSK IMPACT Awards. There are ten winners each year, who receive £30,000, and ten runner up organisations who receive £3,000. The overall winner is awarded an additional £10,000 in unrestricted funding.
In addition to receiving £30,000 in unrestricted funding, winners are invited to join the GSK IMPACT Network – a UK-wide group, which is given access to a unique programme of training, development and networking opportunities, organised by The King’s Fund. The Network offers previous winners the opportunity to develop their staff and provides a forum to share and learn from each other’s experiences and expertise.
Katie Pinnock, Director, UK Charitable Partnerships at GSK, said, “These awards recognise charities that make an incredible difference to many people’s lives right across the United Kingdom. The programme has grown immensely since we started in 1997, and we are extremely proud of the way it has brought people together, enabling them to share knowledge and learn from each other. Each year we are impressed, inspired and moved, not only by the innovation and talent in the work our winning charities undertake, but by the commitment and dedication of everyone involved.”
14 - SCOTTISH PHARMACIST Polypharmacy project keeps Scotland at cutting edge
Ten organisations from across Europe, including Robert Gordon University (RGU), will work together to address health service provision and sustainable management of medication among the elderly.
The SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) project will address these questions and aim to deliver the necessary change in management approaches and tools to help manage multi-medication and adherence to prescribed drugs.
The project is led by the Scottish Government, which is at the forefront of making changes to healthcare guidance and pioneering some of the most advanced thinking in this area of healthcare.
Alpana Mair, the Scottish Government’s Deputy Chief Pharmacist and leader of the project, said, “We have been awarded just over £1 million in funding from Europe and this will allow Scotland to lead on sharing and learning about best practices in managing polypharmacy.
“This is a fantastic opportunity to ensure Scotland remains at the cutting edge of innovative approaches to addressing polypharmacy in Europe. We are delighted to be leading this important piece of work and learning and collaborating with other EU partners.
Alpana Mair, Deputy Chief Pharmaceutical Office and Project Lead
“The project is recognised as an important opportunity to improve the management of polypharmacy for patients with multimorbidities and improve patients outcomes with targeted treatments.”
The consequences of an ageing population across Europe on multiple drug prescription urgently need to be considered and ways of better managing polypharmacy identified.
Safe and effective pharmacotherapy remains one of the greatest challenges in geriatric medicine, where models
RPS Scotland National Seminar
RPS Scotland has launched the programme for their National Seminar on 22-23 August 2015 in Stirling. Earlier this month they announced two key speakers for the Sunday session - Rose Marie Parr
of healthcare delivery lag behind the enormous growth in single disease focused prescribing practices.
The implications for safe, efficient and effective deployment of healthcare resources and sustainability are significant from both healthcare and societal perspectives with the cost of drugs typically representing around 10% of the total healthcare budget.
RGU project leader, Professor Derek Stewart from the University’s School of Pharmacy and Life Sciences, added,
FRPharmS FFRPS, Scotland’s Chief Pharmaceutical Officer, and Laura McIver MRPharmS, Chief Pharmacist, Healthcare Improvement Scotland.
Third speaker is now confirmed as Mark Sampson, Medical Director at MS Cubed Limited, who will be speaking about ‘Communication and patient safety – getting it right the first time’.
“Dr Katie MacLure and I are both delighted to be representing RGU is this key European project. This is a great opportunity to showcase the university and contribute to improving the use of medicines and healthcare of the elderly.”
Representatives from the organisations meet in Edinburgh recently to officially launch the initiative, which was co- funded by the European Commission Consumers, Health, Agriculture and Food Executive Agency.
On the first day of the seminar, RPS Scotland will host an array of stimulating sessions designed to give pharmacists a taste of either the Foundation Framework or The Faculty programme.
The programme and further practical information regarding the event can be found on
www.rpharms.com/ scottishseminar
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48